Evidence map›Paper›PMID 34003878›Full record

ArticlePloS one2021

Pool testing on random and natural clusters of individuals: Optimisation of SARS-CoV-2 surveillance in the presence of low viral load samples.

Michela Baccini, Emilia Rocco, Irene Paganini, Alessandra Mattei, Cristina Sani, Giulia Vannucci, Simonetta Bisanzi, Elena Burroni, Marco Peluso, Armelle Munnia and 6 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 1 country.

Michela BacciniDepartment of Statistics, Computer Science, Applications, University of Florence, Florence, Italy.
Emilia RoccoDepartment of Statistics, Computer Science, Applications, University of Florence, Florence, Italy.
Irene PaganiniRegional Laboratory of Cancer Prevention, Institute for Prevention, Research and Oncological Network (ISPRO), Florence, Italy.ORCID 0000-0001-6867-0244
Alessandra MatteiDepartment of Statistics, Computer Science, Applications, University of Florence, Florence, Italy.
Cristina SaniRegional Laboratory of Cancer Prevention, Institute for Prevention, Research and Oncological Network (ISPRO), Florence, Italy.
Giulia VannucciDepartment of Statistics, Computer Science, Applications, University of Florence, Florence, Italy.
Simonetta BisanziRegional Laboratory of Cancer Prevention, Institute for Prevention, Research and Oncological Network (ISPRO), Florence, Italy.
Elena BurroniRegional Laboratory of Cancer Prevention, Institute for Prevention, Research and Oncological Network (ISPRO), Florence, Italy.
Marco PelusoRegional Laboratory of Cancer Prevention, Institute for Prevention, Research and Oncological Network (ISPRO), Florence, Italy.
Armelle MunniaRegional Laboratory of Cancer Prevention, Institute for Prevention, Research and Oncological Network (ISPRO), Florence, Italy.
Filippo CellaiRegional Laboratory of Cancer Prevention, Institute for Prevention, Research and Oncological Network (ISPRO), Florence, Italy.
Giampaolo PompeoRegional Laboratory of Cancer Prevention, Institute for Prevention, Research and Oncological Network (ISPRO), Florence, Italy.ORCID 0000-0002-4365-427X
Laura MicioRegional Laboratory of Cancer Prevention, Institute for Prevention, Research and Oncological Network (ISPRO), Florence, Italy.
Jessica VitiRegional Laboratory of Cancer Prevention, Institute for Prevention, Research and Oncological Network (ISPRO), Florence, Italy.
Fabrizia MealliDepartment of Statistics, Computer Science, Applications, University of Florence, Florence, Italy.ORCID 0000-0002-1076-9249
Francesca Maria CarozziRegional Laboratory of Cancer Prevention, Institute for Prevention, Research and Oncological Network (ISPRO), Florence, Italy.
Piedmont Reference Center for Epidemiology and Cancer Prevention · ITUniversity of Florence · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Facing the SARS-CoV-2 epidemic requires intensive testing on the population to early identify and isolate infected subjects. During the first emergency phase of the epidemic, RT-qPCR on nasopharyngeal (NP) swabs, which is the most reliable technique to detect ongoing infections, exhibited limitations due to availability of reagents and budget constraints. This stressed the need to develop screening procedures that require fewer resources and are suitable to be extended to larger portions of the population. RT-qPCR on pooled samples from individual NP swabs seems to be a promising technique to improve surveillance. We performed preliminary experimental analyses aimed to investigate the performance of pool testing on samples with low viral load and we evaluated through Monte Carlo (MC) simulations alternative screening protocols based on sample pooling, tailored to contexts characterized by different infection prevalence. We focused on the role of pool size and the opportunity to develop strategies that take advantage of natural clustering structures in the population, e.g. families, school classes, hospital rooms. Despite the use of a limited number of specimens, our results suggest that, while high viral load samples seem to be detectable even in a pool with 29 negative samples, positive specimens with low viral load may be masked by the negative samples, unless smaller pools are used. The results of MC simulations confirm that pool testing is useful in contexts where the infection prevalence is low. The gain of pool testing in saving resources can be very high, and can be optimized by selecting appropriate group sizes. Exploiting natural groups makes the definition of larger pools convenient and potentially overcomes the issue of low viral load samples by increasing the probability of identifying more than one positive in the same pool.

Indexed as

Specimen HandlingCOVID-19COVID-19 Nucleic Acid TestingHumansMonte Carlo MethodNasopharynxReal-Time Polymerase Chain ReactionRNA, ViralSARS-CoV-2Viral LoadRNA, Viral

Identifiers

PMID34003878
PMCPMC8130965
OpenAlexW3118766766

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.